NNNN 株価分析 — Anbio Biotechnology Class A Ordinary Shares (Healthcare >> Medical Instruments & Supplies)
NNNN に関するよくある質問
NNNNのPER(株価収益率)は?
Anbio Biotechnology Class A Ordinary Shares(NNNN)は現在PER 55.06倍で取引されています。
NNNNのROE(自己資本利益率)は?
Anbio Biotechnology Class A Ordinary SharesのROEは23.76%です。
NNNNの配当利回りは?
Anbio Biotechnology Class A Ordinary Sharesの配当利回りは0.00%です。
NNNNの品質スコア(Quality Score)は?
当社のAIはNNNNの総合財務品質を100点中85点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
NNNNは今が買い時ですか?
当社AIのタイミングスコアは100点中28点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
NNNNはどのセクターに属しますか?
Anbio Biotechnology Class A Ordinary SharesはHealthcare >> Medical Instruments & Suppliesセクターに分類されます(NASDAQ市場)
NNNN AI Analysis Summary
Our AI summary for NNNN: Anbio Biotechnology Class A Ordinary Shares (NASDAQ), Healthcare >> Medical Instruments & Supplies sector. The stock currently trades at a P/E of 55.06, ROE of 23.76%, a dividend yield of 0.00%. Its financial Quality Score stands at 85/100 — fundamentals stronger than most of the market. The AI Timing Score is 28/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 10.15
Price
-0.50
(-4.69%)
Day Change
|
|
|---|
NNNN, ファンダメンタルスコアはvery good ( ファンダメンタル = 85) but テクニカルスコアは ...(Sign In to See)...
- Signal
- OUTPERFORM
- Signal Description
- Company financial health is Good
- Reason
-
P/Eが高い。割高銘柄。
ROEの伸びが低い
ROAの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not quite good , financial health is not good , and ability to make profit is very good , ...
| Deepscope 分析 |
|
54% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
1326
|
| Magic Formula Rank by ROE |
1326
|
| Magic Formula Rank by ROIC |
3059
|
| Price | 10.15 |
| PBV / Sector |
15.50 / 3.42
|
| Earning Per Share | 0.16 |
| PE / Sector |
55.06 / 44.33
|
| PEG or PE/Growth / Sector |
0.37 / -1.27
GOOD
|
| Average 1M Daily Value |
0.46 M
GREAT
|
| Average 1W Daily Value |
0.84 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
81% |
| 配当 |
|
8% |
| 登録情報 |
| Analyze Date | 2026-08-05 08:00:36 |
| Symbol | NNNN |
| Name | ANBIO BIOTECHNOLOGY CLASS A ORDINARY SHARES |
| Sector | Healthcare >> Medical Instruments & Supplies |
| Market | NASDAQ |
| Listed Shares | 43.89 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 467.44 / 16,370.55 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: Friedrich-Ebert-Anlage 35-37, Frankfurt am Main, Germany, 60327
Phone: 49 698 7003 9170
Website: https://www.anbiobiotechnology.com
Description: Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions; and SARS-CoV-2 and SARS-CoV-2/Flu A/Flu B antigen rapid test kits. It serves over-the-counter, point-of-care testing, and laboratory markets. Anbio Biotechnology was incorporated in 2021 and is based in Frankfurt am Main, Germany.
ME vs SECTOR Healthcare >> Medical Instruments & Supplies
Click a bubble to view stock details · Bubble size represents market capitalization share
Google